OAR 818-026-0020: Presumption of Degree of Central Nervous System Depression

(1) In any hearing where a question exists as to the degree of central nervous system depression a licensee has induced (i.e., general anesthesia, deep sedation, moderate sedation, minimal sedation or nitrous oxide sedation), the Board may base its findings on, among other things, the types, dosages and routes of administration of drugs administered to the patient and what result can reasonably be expected from those drugs in those dosages and routes administered in a patient of that physical and psychological status. (2) The following drugs are conclusively presumed to produce general anesthesia and may only be used by a licensee holding a General Anesthesia Permit: (a) Ultra short acting barbiturates including, but not limited to, sodium methohexital, thiopental, thiamylal; (b) Alkylphenols — propofol (Diprivan) including precursors or derivatives; (c) Neuroleptic agents; (d) Dissociative agents — ketamine; (e) Etomidate; and (f) Volatile inhalational agents. (3) No permit holder shall have more than one person under any form of sedation or general anesthesia at the same time exclusive of recovery. (4) A licensee that does not hold a Moderate, Deep Sedation or General Anesthesia Permit may not administer, for purpose of anxiolysis or sedation, Benzodiazepines or narcotics in children under 6 years of age. (5) A licensee must ensure a written emergency response protocol is in place for all patients undergoing nitrous oxide, minimal sedation, moderate sedation, deep sedation or general anesthesia.